ABERA BIOSCIENCE AB (8WK) — Financial Flexibility Index
ABERA BIOSCIENCE AB (8WK) has a Financial Flexibility Index of -0.98x as of March 2026. Free cash flow of €-7.44 Million (operating CF €-7.44 Million minus capex €0.00) represents -1% of total liabilities (€7.57 Million). Check ABERA BIOSCIENCE AB cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
ABERA BIOSCIENCE AB Financial Flexibility Index (2022–2025)
Historical Financial Flexibility Index trend for ABERA BIOSCIENCE AB across 4 annual periods. For the full cash flow conversion analysis, see how efficiently does ABERA BIOSCIENCE AB generate cash.
Annual Financial Flexibility Index for ABERA BIOSCIENCE AB (2022–2025)
Year-by-year free cash flow to debt coverage for ABERA BIOSCIENCE AB. Explore ABERA BIOSCIENCE AB (8WK) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.31x | €-2.83 Million | €-3.26 Million | €9.28 Million | ▼ -261.8% |
| 2024 | 0.19x | €933.00K | €-198.00K | €4.95 Million | ▲ +103.9% |
| 2023 | -4.80x | €-17.71 Million | €-17.71 Million | €3.69 Million | ▲ +31.9% |
| 2022 | -7.05x | €-19.69 Million | €-19.69 Million | €2.80 Million | — |